Okuyama A, Nakamura M, Namiki M, Aono T, Matsumoto K, Utsunomiya M, Yoshioka T, Itoh H, Itatani H, Mizutani S
Horm Res. 1986;23(1):21-30. doi: 10.1159/000180284.
Steroidogenic responsiveness and amelioration of sperm number and motility following long-term intramuscular hCG and hMG administration were evaluated in 18 males with hypogonadotrophic hypogonadism (HH). The patients consisted of 13 patients with isolated gonadotrophin deficiency (IGD) and 5 patients hypophysectomized at an early or middle pubertal period. Basal serum levels of testosterone and 17 beta-estradiol were within prepubertal range in all patients before the treatment. Serum testosterone levels reached the normal adult male levels within 12-24 months of the treatment in only 2 of 7 younger patients and 1 of 6 older patients with IGD, whereas in all hypophysectomized patients serum levels of both testosterone and 17 beta-estradiol increased to the levels found in normal adult males within 6 months of the treatment. The mean peak levels of serum testosterone and 17 beta-estradiol, respectively, during the treatment were 2.1 +/- 0.8 (SD) ng/ml and 10.8 +/- 4.9 (SD) pg/ml in younger patients with IGD, 1.4 +/- 0.9 ng/ml and 9.7 +/- 5.1 pg/ml in older patients with IGD and 6.0 +/- 1.2 ng/ml and 34.2 +/- 14.8 pg/ml in hypophysectomized patients. Quantitative improvement in both sperm density and sperm motility were found in 4 of 7 younger patients, 1 of 6 older patients with IGD and all hypophysectomized patients, but only 3 of hypophysectomized patients (3 of 18 patients) could become fertile.
对18名低促性腺激素性腺功能减退症(HH)男性患者进行了长期肌内注射人绒毛膜促性腺激素(hCG)和人绝经期促性腺激素(hMG)后类固醇生成反应性以及精子数量和活力改善情况的评估。患者包括13例孤立性促性腺激素缺乏症(IGD)患者和5例在青春期早期或中期接受垂体切除术的患者。治疗前所有患者的基础血清睾酮和17β - 雌二醇水平均处于青春期前范围。仅7名年轻IGD患者中的2例以及6名老年IGD患者中的1例在治疗12 - 24个月内血清睾酮水平达到正常成年男性水平,而在所有垂体切除患者中,睾酮和17β - 雌二醇的血清水平在治疗6个月内均升至正常成年男性的水平。治疗期间,年轻IGD患者血清睾酮和17β - 雌二醇的平均峰值水平分别为2.1±0.8(标准差)ng/ml和10.8±4.9(标准差)pg/ml,老年IGD患者为1.4±0.9 ng/ml和9.7±5.1 pg/ml,垂体切除患者为6.0±1.2 ng/ml和34.2±14.8 pg/ml。7名年轻患者中的4例、6名老年IGD患者中的1例以及所有垂体切除患者的精子密度和精子活力均有定量改善,但只有3例垂体切除患者(18例患者中的3例)能够生育。